It is worth noting that downregulation of PRMT5 in IDH-mutant WHO G4 astrocytomas or IDH-wildtype glioblastomas is associated with a more favorable prognosis. This evidence concerns the gene PRMT5 and astrocytoma (excluding glioblastoma).